Where do Anika Therapeutics's ratios come from?

Every ratio is computed from Anika Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Anika Therapeutics ANIK Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Net margin	-9.8%+43.3pp	-9.9%+36.6pp	-40.2%+19.2pp	-65.1%-20.6pp	-53.1%-7.7pp
Free cash flow margin	0.9%—	3.9%—	——	——	——
Returns
Return on equity	-8%+23.8pp	-7.5%+23.3pp	-20.2%+23.1pp	-33.9%-3.2pp	-31.8%-0.2pp
Return on assets	-6.1%+18.8pp	-5.7%+18.1pp	-15.7%+19.2pp	-26.9%-1.8pp	-25%+0.5pp
Efficiency
Asset turnover	0.6×+0.2×	0.6×+0.1×	0.4×-0.2×	0.4×-0.2×	0.5×-0.1×
Liquidity
Current ratio	4.5×-1.3×	4.7×-0.2×	5.3×0.0×	6.2×+0.2×	5.7×+0.1×
Quick ratio	3.4×-1.2×	3.9×0.0×	4.5×+0.7×	5.1×+1.2×	4.5×+0.7×
Cash ratio	2×-1.0×	2.6×+0.2×	3×+0.6×	3.3×+0.9×	3×+0.6×
Leverage
Debt-to-equity	0.2×0.0×	0.2×0.0×	0.2×0.0×	0.2×0.0×	0.2×0.0×
Debt-to-assets	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Valuation
Market capitalization	$204.37M+31.6%	$138.59M-42.5%	$135.53M-62.9%	$161.05M-56.4%	$213.07M-43.5%
Enterprise value	$189.09M+48.7%	$107.35M-49.2%	$102.05M-69.1%	$132.88M-60.3%	$185.13M-45.1%
Price / sales	1.8×+0.1×	1.2×-0.8×	1.6×-0.6×	1.7×-0.5×	2×-0.2×
Price / book	1.5×+0.5×	1×-0.6×	0.9×-1.1×	1.1×-0.7×	1.4×-0.4×
EV / sales	1.6×+0.3×	1×-0.8×	1.2×-0.8×	1.4×-0.6×	1.7×-0.3×
Free cash flow yield	0.5%—	3.1%—	——	——	——
Earnings yield	-5.6%+33.5pp	-8.1%+15.3pp	-24.4%+2.3pp	-37.6%-17.6pp	-26.6%-6.3pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Anika Therapeutics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Anika Therapeutics's ratios come from?: Every ratio is computed from Anika Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.